These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 20374068)

  • 1. Temporal stability of urinary and plasma biomarkers of tobacco smoke exposure among cigarette smokers.
    Church TR; Anderson KE; Le C; Zhang Y; Kampa DM; Benoit AR; Yoder AR; Carmella SG; Hecht SS
    Biomarkers; 2010 Jun; 15(4):345-52. PubMed ID: 20374068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined analysis of r-1,t-2,3,c-4-tetrahydroxy-1,2,3,4-tetrahydrophenanthrene and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in smokers' plasma.
    Carmella SG; Yoder A; Hecht SS
    Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1490-4. PubMed ID: 16896038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of human toenail nicotine, cotinine, and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol to levels of these biomarkers in plasma and urine.
    Stepanov I; Hecht SS; Lindgren B; Jacob P; Wilson M; Benowitz NL
    Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1382-6. PubMed ID: 17627002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct analysis of tobacco-specific nitrosamine NNK and its metabolite NNAL in human urine by LC-MS/MS: evidence of linkage to methylated DNA lesions.
    Hu CW; Hsu YW; Chen JL; Tam LM; Chao MR
    Arch Toxicol; 2014 Feb; 88(2):291-9. PubMed ID: 24057573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ratio of a urinary tobacco-specific lung carcinogen metabolite to cotinine is significantly higher in passive than in active smokers.
    Vogel RI; Carmella SG; Stepanov I; Hatsukami DK; Hecht SS
    Biomarkers; 2011 Sep; 16(6):491-7. PubMed ID: 21812592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary levels of cigarette smoke constituent metabolites are prospectively associated with lung cancer development in smokers.
    Yuan JM; Gao YT; Murphy SE; Carmella SG; Wang R; Zhong Y; Moy KA; Davis AB; Tao L; Chen M; Han S; Nelson HH; Yu MC; Hecht SS
    Cancer Res; 2011 Nov; 71(21):6749-57. PubMed ID: 22028322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urine cotinine underestimates exposure to the tobacco-derived lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in passive compared with active smokers.
    Benowitz N; Goniewicz ML; Eisner MD; Lazcano-Ponce E; Zielinska-Danch W; Koszowski B; Sobczak A; Havel C; Jacob P
    Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2795-800. PubMed ID: 20805316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cigarettes with different nicotine levels affect sensory perception and levels of biomarkers of exposure in adult smokers.
    McKinney DL; Frost-Pineda K; Oldham MJ; Fisher MT; Wang J; Gogova M; Kobal G
    Nicotine Tob Res; 2014 Jul; 16(7):948-60. PubMed ID: 24638852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers of secondhand smoke exposure in automobiles.
    Jones IA; St Helen G; Meyers MJ; Dempsey DA; Havel C; Jacob P; Northcross A; Hammond SK; Benowitz NL
    Tob Control; 2014 Jan; 23(1):51-7. PubMed ID: 23349229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of urine cotinine and the tobacco-specific nitrosamine metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) and their ratio to discriminate active from passive smoking.
    Goniewicz ML; Eisner MD; Lazcano-Ponce E; Zielinska-Danch W; Koszowski B; Sobczak A; Havel C; Jacob P; Benowitz NL
    Nicotine Tob Res; 2011 Mar; 13(3):202-8. PubMed ID: 21330276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in smokers in the United States: NHANES 2007-2008.
    Xia Y; Bernert JT; Jain RB; Ashley DL; Pirkle JL
    Biomarkers; 2011 Mar; 16(2):112-9. PubMed ID: 21114376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial differences in exposure and glucuronidation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK).
    Muscat JE; Djordjevic MV; Colosimo S; Stellman SD; Richie JP
    Cancer; 2005 Apr; 103(7):1420-6. PubMed ID: 15726545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of maternal tobacco smoking or exposure to second-hand smoke on the levels of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in urine of mother and the first urine of newborn.
    Florek E; Piekoszewski W; Basior A; Merritt AT; Mazela J; Lechowicz W; Kornacka MK; Kramer L
    J Physiol Pharmacol; 2011 Jun; 62(3):377-83. PubMed ID: 21893699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of urinary biomarkers of tobacco and carcinogen exposure in smokers.
    Murphy SE; Link CA; Jensen J; Le C; Puumala SS; Hecht SS; Carmella SG; Losey L; Hatsukami DK
    Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1617-23. PubMed ID: 15466978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary tobacco smoke-constituent biomarkers for assessing risk of lung cancer.
    Yuan JM; Butler LM; Stepanov I; Hecht SS
    Cancer Res; 2014 Jan; 74(2):401-11. PubMed ID: 24408916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study to evaluate the effect on Mouth Level Exposure and biomarkers of exposure estimates of cigarette smoke exposure following a forced switch to a lower ISO tar yield cigarette.
    Shepperd CJ; Eldridge AC; Errington G; Dixon M
    Regul Toxicol Pharmacol; 2011 Dec; 61(3 Suppl):S13-24. PubMed ID: 21672597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exposure to different sources of second-hand smoke during pregnancy and its effect on urinary cotinine and tobacco-specific nitrosamine (NNAL) concentrations.
    Vardavas CI; Fthenou E; Patelarou E; Bagkeris E; Murphy S; Hecht SS; Connolly GN; Chatzi L; Kogevinas M
    Tob Control; 2013 May; 22(3):194-200. PubMed ID: 22253001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial differences in the relationship between number of cigarettes smoked and nicotine and carcinogen exposure.
    Benowitz NL; Dains KM; Dempsey D; Wilson M; Jacob P
    Nicotine Tob Res; 2011 Sep; 13(9):772-83. PubMed ID: 21546441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of human urine for pyridine-N-oxide metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco-specific lung carcinogen.
    Carmella SG; Borukhova A; Akerkar SA; Hecht SS
    Cancer Epidemiol Biomarkers Prev; 1997 Feb; 6(2):113-20. PubMed ID: 9037562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum cotinine and urinary 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanonol levels among non-Hispanic Asian American smokers and nonsmokers as compared to other race/ethnicities: data from NHANES 2011-2012.
    Jain RB
    Chemosphere; 2015 Feb; 120():584-91. PubMed ID: 25462301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.